{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T22:18:15Z","timestamp":1785190695327,"version":"3.55.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00210-025-04740-5","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T05:43:19Z","timestamp":1761370999000},"page":"4707-4735","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neuroprotective mechanisms of sodium butyrate in Parkinson\u2019s disease in preclinical rodent models: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"399","author":[{"given":"Leila","family":"Hosseini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azizeh","family":"Farshbaf-Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezoo Moini","family":"Jazani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0674-5025","authenticated-orcid":false,"given":"Leila","family":"Maghsoumi-Norouzabad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,25]]},"reference":[{"key":"4740_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126367","author":"C Avagliano","year":"2022","unstructured":"Avagliano C, Coretti L, Lama A, Pirozzi C, De Caro C, De Biase D, Turco L, Mollica MP, Paciello O, Calignano A, Meli R, Lembo F, Mattace Raso G (2022) Dual-hit model of Parkinson\u2019s disease: impact of dysbiosis on 6-hydroxydopamine-insulted mice-neuroprotective and anti-inflammatory effects of butyrate. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23126367","journal-title":"Int J Mol Sci"},{"key":"4740_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1079\/PNS2002212","volume":"62","author":"KE Bach Knudsen","year":"2003","unstructured":"Bach Knudsen KE, Serena A, Canibe N, Juntunen KS (2003) New insight into butyrate metabolism. Proc Nutr Soc 62:81\u201386","journal-title":"Proc Nutr Soc"},{"key":"4740_CR3","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1007\/s11064-021-03369-z","volume":"46","author":"AB Bayazid","year":"2021","unstructured":"Bayazid AB, Jang YA, Kim YM, Kim JG, Lim BO (2021) Neuroprotective effects of sodium butyrate through suppressing neuroinflammation and modulating antioxidant enzymes. Neurochem Res 46:2348\u20132358","journal-title":"Neurochem Res"},{"key":"4740_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2021.112743","volume":"159","author":"AB Bayazid","year":"2022","unstructured":"Bayazid AB, Kim JG, Azam S, Jeong SA, Kim DH, Park CW, Lim BO (2022) Sodium butyrate ameliorates neurotoxicity and exerts anti-inflammatory effects in high fat diet-fed mice. Food Chem Toxicol 159:112743","journal-title":"Food Chem Toxicol"},{"key":"4740_CR5","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.bbadis.2010.06.006","volume":"1802","author":"M Bisaglia","year":"2010","unstructured":"Bisaglia M, Soriano ME, Arduini I, Mammi S, Bubacco L (2010) Molecular characterization of dopamine-derived quinones reactivity toward NADH and glutathione: implications for mitochondrial dysfunction in Parkinson disease. Biochimica Et Biophysica Acta (BBA)-Molecular Basis of Disease 1802:699\u2013706","journal-title":"Biochimica Et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"key":"4740_CR6","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.2174\/0929867325666180226094351","volume":"26","author":"S Cerri","year":"2019","unstructured":"Cerri S, Blandini F (2019) Role of autophagy in Parkinson\u2019s disease. Curr Med Chem 26:3702\u20133718","journal-title":"Curr Med Chem"},{"key":"4740_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/01.wnf.0000145509.84389.ce","volume":"27","author":"M Chalimoniuk","year":"2004","unstructured":"Chalimoniuk M, Stepien A, Strosznajder J (2004) Pergolide mesylate, a dopaminergic receptor agonist, applied with L-DOPA enhances serum antioxidant enzyme activity in Parkinson disease. Clin Neuropharmacol 27:223\u2013229","journal-title":"Clin Neuropharmacol"},{"key":"4740_CR8","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.3233\/JPD-223461","volume":"12","author":"DG Chan","year":"2022","unstructured":"Chan DG, Ventura K, Villeneuve A, Du Bois P, Holahan MR (2022) Exploring the connection between the gut microbiome and Parkinson\u2019s disease symptom progression and pathology: implications for supplementary treatment options. J Parkinsons Dis 12:2339\u20132352","journal-title":"J Parkinsons Dis"},{"key":"4740_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejphar.2015.09.029","volume":"768","author":"Y Chen","year":"2015","unstructured":"Chen Y, Zhang Y, Li L, H\u00f6lscher C (2015) Neuroprotective effects of geniposide in the MPTP mouse model of Parkinson\u2019s disease. Eur J Pharmacol 768:21\u201327","journal-title":"Eur J Pharmacol"},{"key":"4740_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ebiom.2018.03.030","volume":"30","author":"G Chen","year":"2018","unstructured":"Chen G, Ran X, Li B, Li Y, He D, Huang B, Fu S, Liu J, Wang W (2018) Sodium butyrate inhibits inflammation and maintains epithelium barrier integrity in a TNBS-induced inflammatory bowel disease mice model. EBioMedicine 30:317\u2013325","journal-title":"EBioMedicine"},{"key":"4740_CR11","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s12264-023-01123-9","volume":"40","author":"WX Duan","year":"2024","unstructured":"Duan WX, Wang F, Liu JY, Liu CF (2024) Relationship between short-chain fatty acids and Parkinson\u2019s disease: a review from pathology to clinic. Neurosci Bull 40:500\u2013516","journal-title":"Neurosci Bull"},{"key":"4740_CR12","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nn.4030","volume":"18","author":"D Erny","year":"2015","unstructured":"Erny D, Hrab\u011b de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E, Keren-Shaul H, Mahlakoiv T, Jakobshagen K, Buch T, Schwierzeck V, Uterm\u00f6hlen O, Chun E, Garrett WS, McCoy KD, Diefenbach A, Staeheli P, Stecher B, Amit I, Prinz M (2015) Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 18:965\u2013977","journal-title":"Nat Neurosci"},{"key":"4740_CR13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.it.2008.05.002","volume":"29","author":"HM Gao","year":"2008","unstructured":"Gao HM, Hong JS (2008) Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol 29:357\u2013365","journal-title":"Trends Immunol"},{"key":"4740_CR14","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3390\/nu15040930","volume":"15","author":"T-T Guo","year":"2023","unstructured":"Guo T-T, Zhang Z, Sun Y, Zhu R-Y, Wang F-X, Ma L-J, Jiang L, Liu H-D (2023) Neuroprotective effects of sodium butyrate by restoring gut microbiota and inhibiting TLR4 signaling in mice with MPTP-induced Parkinson\u2019s disease. Nutrients 15:930","journal-title":"Nutrients"},{"key":"4740_CR15","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1111\/j.1471-4159.1992.tb10990.x","volume":"59","author":"B Halliwell","year":"1992","unstructured":"Halliwell B (1992) Reactive oxygen species and the central nervous system. J Neurochem 59:1609\u20131623","journal-title":"J Neurochem"},{"key":"4740_CR16","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/NEN.0b013e318211c86a","volume":"70","author":"S Higashi","year":"2011","unstructured":"Higashi S, Moore DJ, Minegishi M, Kasanuki K, Fujishiro H, Kabuta T, Togo T, Katsuse O, Uchikado H, Furukawa Y (2011) Localization of MAP1-LC3 in vulnerable neurons and Lewy bodies in brains of patients with dementia with Lewy bodies. J Neuropathol Exp Neurol 70:264\u2013280","journal-title":"J Neuropathol Exp Neurol"},{"key":"4740_CR17","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol 8:382\u2013397","journal-title":"Lancet Neurol"},{"key":"4740_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RBM, Leenaars M, Ritskes-Hoitinga M, Langendam MW (2014) Sircle\u2019s risk of bias tool for animal studies. BMC Med Res Methodol 14:43","journal-title":"BMC Med Res Methodol"},{"key":"4740_CR19","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1016\/j.jmb.2020.01.037","volume":"432","author":"X Hou","year":"2020","unstructured":"Hou X, Watzlawik JO, Fiesel FC, Springer W (2020) Autophagy in Parkinson\u2019s disease. J Mol Biol 432:2651\u20132672","journal-title":"J Mol Biol"},{"key":"4740_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2021.111376","volume":"150","author":"Y Hou","year":"2021","unstructured":"Hou Y, Li X, Liu C, Zhang M, Zhang X, Ge S, Zhao L (2021) Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson\u2019s disease. Exp Gerontol 150:111376","journal-title":"Exp Gerontol"},{"key":"4740_CR21","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/kjm2.12745","volume":"39","author":"L-L Ji","year":"2023","unstructured":"Ji L-L, Huang T-T, Mao L-L, Xu Y-F, Chen W-Y, Wang W-W, Wang L-H (2023) The gut microbiota metabolite butyrate mitigates MPTP\/MPP+-induced Parkinson\u2019s disease by inhibiting the JAK2\/STAT3 signaling pathway. Kaohsiung J Med Sci 39:1002\u20131010","journal-title":"Kaohsiung J Med Sci"},{"key":"4740_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109451","volume":"113","author":"Z Jiang","year":"2022","unstructured":"Jiang Z, Yin X, Wang M, Wang Y, Li F, Gao Y, Han G, Gao Z, Wang Z (2022) \u03b2-Hydroxybutyrate alleviates pyroptosis in MPP(+)\/MPTP-induced Parkinson\u2019s disease models via inhibiting STAT3\/NLRP3\/GSDMD pathway. Int Immunopharmacol 113:109451","journal-title":"Int Immunopharmacol"},{"key":"4740_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.pneurobio.2016.04.006","volume":"155","author":"V Joers","year":"2017","unstructured":"Joers V, Tansey MG, Mulas G, Carta AR (2017) Microglial phenotypes in Parkinson\u2019s disease and animal models of the disease. Prog Neurobiol 155:57\u201375","journal-title":"Prog Neurobiol"},{"key":"4740_CR24","doi-asserted-by":"crossref","unstructured":"Kakoty V, K CS, Dubey SK, Yang CH, Taliyan R (2021) Neuroprotective effects of trehalose and sodium butyrate on preformed fibrillar form of \u03b1-synuclein-induced rat model of Parkinson's disease. ACS Chem Neurosci 12: 2643\u20132660","DOI":"10.1021\/acschemneuro.1c00144"},{"key":"4740_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3389\/fnagi.2019.00102","volume":"11","author":"JH Ko","year":"2019","unstructured":"Ko JH, Lee H, Kim SN, Park HJ (2019) Does acupuncture protect dopamine neurons in Parkinson\u2019s disease rodent model?: a systematic review and meta-analysis. Front Aging Neurosci 11:102","journal-title":"Front Aging Neurosci"},{"key":"4740_CR26","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s12035-012-8267-8","volume":"47","author":"CM Lema Tom\u00e9","year":"2013","unstructured":"Lema Tom\u00e9 CM, Tyson T, Rey NL, Grathwohl S, Britschgi M, Brundin P (2013) Inflammation and \u03b1-synuclein\u2019s prion-like behavior in Parkinson\u2019s disease\u2013is there a link? Mol Neurobiol 47:561\u2013574","journal-title":"Mol Neurobiol"},{"key":"4740_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40035-019-0162-z","volume":"8","author":"G Li","year":"2019","unstructured":"Li G, Ma J, Cui S, He Y, Xiao Q, Liu J, Chen S (2019) Parkinson\u2019s disease in China: a forty-year growing track of bedside work. Transl Neurodegener 8:22","journal-title":"Transl Neurodegener"},{"key":"4740_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/jep.13159","author":"L Lin","year":"2019","unstructured":"Lin L (2019) Comparison of four heterogeneity measures for meta-analysis. J Eval Clin Pract. https:\/\/doi.org\/10.1111\/jep.13159","journal-title":"J Eval Clin Pract"},{"key":"4740_CR29","unstructured":"Liu L, Xiong N, Huang J, Zhang G, Xu X, Han C, Li J, Jiang H, Yang J, Shen Y, Wang T (2015) Neuroprotective effects of sodium butyrate against rotenone neurotoxicity in both wild-type and VMAT2 heterozygote knockout mice."},{"key":"4740_CR30","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jns.2017.08.3235","volume":"381","author":"J Liu","year":"2017","unstructured":"Liu J, Wang F, Liu S, Du J, Hu X, Xiong J, Fang R, Chen W, Sun J (2017) Sodium butyrate exerts protective effect against Parkinson\u2019s disease in mice via stimulation of glucagon like peptide-1. J Neurol Sci 381:176\u2013181","journal-title":"J Neurol Sci"},{"key":"4740_CR31","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1021\/acs.jafc.8b06359","volume":"67","author":"J Liu","year":"2019","unstructured":"Liu J, Chang G, Huang J, Wang Y, Ma N, Roy AC, Shen X (2019) Sodium butyrate inhibits the inflammation of lipopolysaccharide-induced acute lung injury in mice by regulating the toll-like receptor 4\/nuclear factor \u03baB signaling pathway. J Agric Food Chem 67:1674\u20131682","journal-title":"J Agric Food Chem"},{"key":"4740_CR32","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1161\/01.STR.0000125719.25853.20","volume":"35","author":"MR Macleod","year":"2004","unstructured":"Macleod MR, O\u2019Collins T, Howells DW, Donnan GA (2004) Pooling of animal experimental data reveals influence of study design and publication bias. Stroke 35:1203\u20131208","journal-title":"Stroke"},{"key":"4740_CR33","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/mds.25898","volume":"29","author":"AD Macleod","year":"2014","unstructured":"Macleod AD, Taylor KS, Counsell CE (2014) Mortality in Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord 29:1615\u20131622","journal-title":"Mov Disord"},{"key":"4740_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4:1","journal-title":"Syst Rev"},{"key":"4740_CR35","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/hmg\/ddx114","volume":"26","author":"I Paiva","year":"2017","unstructured":"Paiva I, Pinho R, Pavlou MA, Hennion M, Wales P, Sch\u00fctz AL, Rajput A, Szego \u00c9M, Kerimoglu C, Gerhardt E, Rego AC, Fischer A, Bonn S, Outeiro TF (2017) Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage. Hum Mol Genet 26:2231\u20132246","journal-title":"Hum Mol Genet"},{"key":"4740_CR36","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3390\/ijms21031170","volume":"21","author":"E Palasz","year":"2020","unstructured":"Palasz E, Wysocka A, Gasiorowska A, Chalimoniuk M, Niewiadomski W, Niewiadomska G (2020) BDNF as a promising therapeutic agent in Parkinson\u2019s disease. Int J Mol Sci 21:1170","journal-title":"Int J Mol Sci"},{"key":"4740_CR37","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1007\/s12035-016-0149-z","volume":"54","author":"R Patnala","year":"2017","unstructured":"Patnala R, Arumugam TV, Gupta N, Dheen ST (2017) HDAC inhibitor sodium butyrate-mediated epigenetic regulation enhances neuroprotective function of microglia during ischemic stroke. Mol Neurobiol 54:6391\u20136411","journal-title":"Mol Neurobiol"},{"issue":"Suppl 1","key":"4740_CR38","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1016\/j.parkreldis.2015.09.004","volume":"22","author":"RF Pfeiffer","year":"2016","unstructured":"Pfeiffer RF (2016) Non-motor symptoms in Parkinson\u2019s disease. Parkinsonism Relat Disord 22(Suppl 1):S119-122","journal-title":"Parkinsonism Relat Disord"},{"key":"4740_CR39","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbi.2018.02.016","volume":"70","author":"Y Qian","year":"2018","unstructured":"Qian Y, Yang X, Xu S, Wu C, Song Y, Qin N, Chen SD, Xiao Q (2018) Alteration of the fecal microbiota in Chinese patients with Parkinson\u2019s disease. Brain Behav Immun 70:194\u2013202","journal-title":"Brain Behav Immun"},{"key":"4740_CR40","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1007\/s11064-020-03074-3","volume":"45","author":"CM Qiao","year":"2020","unstructured":"Qiao CM, Sun MF, Jia XB, Li Y, Zhang BP, Zhao LP, Shi Y, Zhou ZL, Zhu YL, Cui C, Shen YQ (2020a) Sodium butyrate exacerbates Parkinson\u2019s disease by aggravating neuroinflammation and colonic inflammation in MPTP-induced mice model. Neurochem Res 45:2128\u20132142","journal-title":"Neurochem Res"},{"key":"4740_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2019.111772","volume":"387","author":"CM Qiao","year":"2020","unstructured":"Qiao CM, Sun MF, Jia XB, Shi Y, Zhang BP, Zhou ZL, Zhao LP, Cui C, Shen YQ (2020b) Sodium butyrate causes \u03b1-synuclein degradation by an Atg5-dependent and PI3K\/Akt\/mTOR-related autophagy pathway. Exp Cell Res 387:111772","journal-title":"Exp Cell Res"},{"key":"4740_CR42","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1016\/j.neuropharm.2012.01.026","volume":"62","author":"P Rane","year":"2012","unstructured":"Rane P, Shields J, Heffernan M, Guo Y, Akbarian S, King JA (2012) The histone deacetylase inhibitor, sodium butyrate, alleviates cognitive deficits in pre-motor stage PD. Neuropharmacology 62:2409\u20132412","journal-title":"Neuropharmacology"},{"key":"4740_CR43","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.aag2590","volume":"353","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM (2016) How neuroinflammation contributes to neurodegeneration. Science 353:777\u2013783","journal-title":"Science"},{"key":"4740_CR44","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.bbr.2015.05.052","volume":"291","author":"S Sharma","year":"2015","unstructured":"Sharma S, Taliyan R, Singh S (2015) Beneficial effects of sodium butyrate in 6-OHDA induced neurotoxicity and behavioral abnormalities: modulation of histone deacetylase activity. Behav Brain Res 291:306\u2013314","journal-title":"Behav Brain Res"},{"key":"4740_CR45","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.3390\/nu15204466","volume":"15","author":"Y Shin","year":"2023","unstructured":"Shin Y, Han S, Kwon J, Ju S, Choi TG, Kang I, Kim SS (2023) Roles of short-chain fatty acids in inflammatory bowel disease. Nutrients 15:4466","journal-title":"Nutrients"},{"key":"4740_CR46","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jnutbio.2019.03.021","volume":"69","author":"S Srivastav","year":"2019","unstructured":"Srivastav S, Neupane S, Bhurtel S, Katila N, Maharjan S, Choi H, Hong JT, Choi DY (2019) Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity. J Nutr Biochem 69:73\u201386","journal-title":"J Nutr Biochem"},{"key":"4740_CR47","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.neuroscience.2013.04.037","volume":"246","author":"R St Laurent","year":"2013","unstructured":"St Laurent R, O\u2019Brien LM, Ahmad ST (2013) Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson\u2019s disease. Neuroscience 246:382\u2013390","journal-title":"Neuroscience"},{"key":"4740_CR48","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/395895","volume":"2015","author":"J Sun","year":"2015","unstructured":"Sun J, Wang F, Li H, Zhang H, Jin J, Chen W, Pang M, Yu J, He Y, Liu J (2015) Neuroprotective effect of sodium butyrate against cerebral ischemia\/reperfusion injury in mice. BioMed Res Int 2015:395895","journal-title":"BioMed Res Int"},{"key":"4740_CR49","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbi.2018.02.005","volume":"70","author":"MF Sun","year":"2018","unstructured":"Sun MF, Zhu YL, Zhou ZL, Jia XB, Xu YD, Yang Q, Cui C, Shen YQ (2018) Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson\u2019s disease mice: gut microbiota, glial reaction and TLR4\/TNF-\u03b1 signaling pathway. Brain Behav Immun 70:48\u201360","journal-title":"Brain Behav Immun"},{"key":"4740_CR50","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1007\/s11064-022-03691-0","volume":"47","author":"S Tiwari","year":"2022","unstructured":"Tiwari S, Gupta P, Singh A, Chaturvedi S, Wahajuddin M, Mishra A, Singh S (2022) 4-phenylbutyrate mitigates the motor impairment and dopaminergic neuronal death during Parkinson\u2019s disease pathology via targeting VDAC1 mediated mitochondrial function and astrocytes activation. Neurochem Res 47:3385\u20133401","journal-title":"Neurochem Res"},{"key":"4740_CR51","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","volume":"32","author":"MM Unger","year":"2016","unstructured":"Unger MM, Spiegel J, Dillmann KU, Grundmann D, Philippeit H, B\u00fcrmann J, Fa\u00dfbender K, Schwiertz A, Sch\u00e4fer KH (2016) Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls. Parkinsonism Relat Disord 32:66\u201372","journal-title":"Parkinsonism Relat Disord"},{"key":"4740_CR52","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fnagi.2020.00277","volume":"12","author":"Y Wang","year":"2020","unstructured":"Wang Y, Wei N, Li X (2020) Preclinical evidence and possible mechanisms of baicalein for rats and mice with Parkinson\u2019s disease: a systematic review and meta-analysis. Front Aging Neurosci 12:277","journal-title":"Front Aging Neurosci"},{"key":"4740_CR53","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.parkreldis.2010.02.007","volume":"16","author":"A Wypijewska","year":"2010","unstructured":"Wypijewska A, Galazka-Friedman J, Bauminger ER, Wszolek ZK, Schweitzer KJ, Dickson DW, Jaklewicz A, Elbaum D, Friedman A (2010) Iron and reactive oxygen species activity in parkinsonian substantia nigra. Parkinsonism Relat Disord 16:329\u2013333","journal-title":"Parkinsonism Relat Disord"},{"key":"4740_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005515","volume":"4","author":"M Xilouri","year":"2009","unstructured":"Xilouri M, Vogiatzi T, Vekrellis K, Park D, Stefanis L (2009) Abberant \u03b1-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. PLoS ONE 4:e5515","journal-title":"PLoS ONE"},{"key":"4740_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/nu14194163","author":"RC Xu","year":"2022","unstructured":"Xu RC, Miao WT, Xu JY, Xu WX, Liu MR, Ding ST, Jian YX, Lei YH, Yan N, Liu HD (2022) Neuroprotective effects of sodium butyrate and monomethyl fumarate treatment through GPR109A modulation and intestinal barrier restoration on PD mice. Nutrients. https:\/\/doi.org\/10.3390\/nu14194163","journal-title":"Nutrients"},{"key":"4740_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1194","volume":"12","author":"Y Xu","year":"2024","unstructured":"Xu Y, Wen L, Tang Y, Zhao Z, Xu M, Wang T, Chen Z (2024) Sodium butyrate activates the K(ATP) channels to regulate the mechanism of Parkinson\u2019s disease microglia model inflammation. Immun Inflamm Dis 12:e1194","journal-title":"Immun Inflamm Dis"},{"key":"4740_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2021.147749","volume":"1776","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Xu S, Qian Y, He X, Mo C, Yang X, Xiao Q (2022) Sodium butyrate attenuates rotenone-induced toxicity by activation of autophagy through epigenetically regulating PGC-1\u03b1 expression in PC12 cells. Brain Res 1776:147749","journal-title":"Brain Res"},{"key":"4740_CR58","doi-asserted-by":"publisher","first-page":"1099018","DOI":"10.3389\/fnagi.2023.1099018","volume":"15","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Xu S, Qian Y, Mo C, Ai P, Yang X, Xiao Q (2023) Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson\u2019s disease by regulating gut microbiota. Front Aging Neurosci 15:1099018","journal-title":"Front Aging Neurosci"},{"key":"4740_CR59","doi-asserted-by":"crossref","unstructured":"Zhao J, Hu J, Ma X (2021) Sodium decanoate improves intestinal epithelial barrier and antioxidation via activating g protein-coupled receptor-43. Nutrients 13","DOI":"10.3390\/nu13082756"},{"key":"4740_CR60","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s13311-019-00719-2","volume":"16","author":"ZL Zhou","year":"2019","unstructured":"Zhou ZL, Jia XB, Sun MF, Zhu YL, Qiao CM, Zhang BP, Zhao LP, Yang Q, Cui C, Chen X, Shen YQ (2019) Neuroprotection of fasting mimicking diet on MPTP-induced Parkinson\u2019s disease mice via gut microbiota and metabolites. Neurotherapeutics 16:741\u2013760","journal-title":"Neurotherapeutics"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04740-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04740-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04740-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T04:02:56Z","timestamp":1776225776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04740-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,25]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4740"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04740-5","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,25]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Tabriz University of Medical Sciences, Tabriz, Iran (Ethics code; IR.TBZMED.REC.1403.921).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}